OncoDaily

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation? - Dr. Sandler shares how Revolution Medicines evolved from its early beginnings to becoming a leader in RAS-targeted therapies. He explains the scientific rationale behind targeting RAS-driven tumor.

Asking Company Members Why They Recommend UICC Membership to Other Organizations - Union for International Cancer Control @uicc oncodaily.com/voices/uicc-54…

@maraantonoff @AATSHQ @WomenInThoracic We would like to inform you that your post has been published on OncoDaily. Thank you for sharing! oncodaily.com/science/mara-a…

📈 Progress deserves celebration. Gaps deserve attention. Appreciate @AATSHQ highlighting our @WomenInThoracic work showing notable representation of 🚺 as 1st authors, yet persistent disparities in senior authorship. Progress comes from mentorship, sponsorship, & collaboration.

SBRT Plus Immunotherapy Achieves Complete Response in Advanced HCC Case - Deepak Gupta @deepakonco oncodaily.com/voices/deepak-…

@drshieldsmd @lungoncdoc @SclcSMASHERS @YoungLungCancer @LUNGevity @OncBrothers @LungCancerRx @GO2forLungCancr @OncodailyLung @IUCancerCenter We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/voices/misty-d…

Why does support matter when facing lung cancer diagnosis, like small cell lung cancer? Support changes the experience of living well with cancer. Build your tribe. Find your people. Maximize your support. No one deserves lung cancer. No one should face this diagnosis alone. We are here for you. @LUNGevity @SclcSMASHERS @lungoncdoc @nursesteagall #LCSM @SCLCYIForum #SCLC

The Medical Al Benchmark Race Can't Answer the Question That Matters Most - Allen Li (@LiAllenMD) oncodaily.com/voices/allen-l…

Myeloma Paper of the Day, July 19th, Suggested by Robert Orlowski (@Myeloma_Doc) oncodaily.com/science/myelom…

Why the U.S. Healthcare System Is Failing Despite Record Spending? - Kashyap Patel @KashyappatelMd oncodaily.com/voices/kashyap…

New Mongolian Study on COVID-19 Vaccine Immunity Duration - Tsetsegsaikhan Batmunkh (@TsegiBatmunkh) oncodaily.com/science/tsetse…

How V(D)J Recombination Permanently Changed The Way We See Biology - Alicia Zhou (@ay_zhou) oncodaily.com/voices/alicia-…

@IGCSociety Honors 2026 Award Recipients for Excellence in Gynecologic Oncology oncodaily.com/voices/igcs545…

Can a celebrity charity event lose its message? W Korea's LOVE YOUR W breast cancer gala sparked global debate after RM, J-Hope, and V of BTS attended an event many felt looked more like a fashion party than a health campaign. What happened next and how ARMY changed the conversation is the real story. @bts_bighit 🔗oncodaily.com/stories/celebr…

Creating Systems in Service of People Where These Systems Did Not Exist - Pat Garcia-Gonzalez (@PatGarciaGonzal) @Novartis @themaxfndn oncodaily.com/voices/pat-gar…

Honored to be Presenting at the 2026 Best of ASCO Conference - Prerna Mewawalla @myelomadoctor oncodaily.com/career/prerna-…

Rare Disease Trials Face Ongoing Challenges in Demonstrating Therapeutic Value - Zhaohui Su @ZhaohuiSu @VeristatCRO oncodaily.com/voices/zhaohui…

@bdermanmd We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/science/ben-de…

Congratulations to the ENDURANCE investigators on an impactful trial - they should be applauded for running a successful cooperative group phase 3 trial with two randomizations! My thoughts below... ENDURANCE enrolled patients without high-risk disease and without intention for ASCT. The 1st randomization evaluated KRd vs. VRd (no difference in PFS). The 2nd randomization evaluated 2 years vs indefinite lenalidomide maintenance with OS as the primary endpoint. After 9 years of follow-up, there is no difference in OS! Let's dive in and take a closer look... nejm.org/doi/full/10.10…

ADC-IO Combinations in Urothelial Cancer at the 2026 SITC EU Immuno-Oncology Drug Development Summit @sitcancer oncodaily.com/science/sitc-5…

Philadelphia Chromosome Positivity Should Not Be Treated as a Binary Label Before CAR-T - Aishee Pal Sadhu oncodaily.com/voices/aishee-…

@GlopesMd @FIFAcom @FIFAWorldCup @WHO What the 2026 World Cup Can Teach Us About Global Oncology - GILBERTO de lima LOPES Junior @GlopesMd @FIFAcom @FIFAWorldCup @WHO oncodaily.com/voices/gilbert…

As we reach the last two games of @FIFAcom 2026 @FIFAWorldCup here is my take on where we are on Cancer Control based on the @WHO’s Global Status Report on Cancer 2026: The Future We Choose Together. The Quarterfinals: What the World Cup Can Teach Us About Where We Are and Where We’re Going in Global Oncology | ASCO Connection connection.asco.org/do/quarterfina… @asco @myESMO @OncoAlert @Latinamd @uicc @SylvesterCancer @OncBrothers @oncodaily @Jani_Chinmay @JCOGO_ASCO @JCO_ASCO

International Collaborations Across The Christie, MCRC, and University of Manchester - Rachel Chown @OfficialUoM @TheChristieNHS oncodaily.com/voices/rachel-…

Giuseppe Curigliano Discusses Designing Sequential Studies in ADC - Abirami Sivapiragasam @AbiSivaMD @curijoey oncodaily.com/voices/abi-siv…